FATIGUE POST VIRAL
Clinical trials for FATIGUE POST VIRAL explained in plain language.
Never miss a new study
Get alerted when new FATIGUE POST VIRAL trials appear
Sign up with your email to follow new studies for FATIGUE POST VIRAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cord blood infusion offers hope for long COVID sufferers
Disease control AVAILABLEThis study offers expanded access to an infusion of human umbilical cord blood (REGENECYTE) for adults with Long COVID who are not eligible for other clinical trials. The goal is to see if this treatment can help control ongoing symptoms like chronic fatigue. Participants must ha…
Matched conditions: FATIGUE POST VIRAL
Sponsor: StemCyte, Inc. • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
New therapy aims to ease chronic fatigue in everyday patients
Symptom relief Recruiting nowThis study looks at whether a type of talking therapy (transdiagnostic cognitive behavioral therapy) can help reduce fatigue in primary care patients. About 190 adults aged 18-67 with severe fatigue lasting at least 3 months will be randomly assigned to either the therapy or usua…
Matched conditions: FATIGUE POST VIRAL
Phase: NA • Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated May 26, 2026 08:44 UTC
-
Why do some teens stay tired after mono? new study seeks answers
Knowledge-focused Recruiting nowThis study aims to understand why some adolescents and young adults feel tired for months after an Epstein-Barr virus infection (mono). Researchers will follow 150 infected individuals and 150 healthy controls for six months, using brain scans, immune tests, and behavioral experi…
Matched conditions: FATIGUE POST VIRAL
Sponsor: University Hospital, Akershus • Aim: Knowledge-focused
Last updated May 26, 2026 08:40 UTC